INTERNATIONAL PATENT: ALTO NEUROSCIENCE, INC. FILES APPLICATION FOR "TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS IN PATIENTS WITH PROMINENT ANHEDONIA USING IRDABISANT AS A MONOTHERAPY OR IN COMBINATION WITH AN ANTIPSYCHOTIC AGENT"

GENEVA, May 19 -- ALTO NEUROSCIENCE, INC. (650 Castro Street, Suite 450Mountain View, California 94041) filed a patent application (PCT/US2024/053898) for "TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS IN PATIENTS WITH PROMINENT ANHEDONIA USING IRDABISANT AS A MONOTHERAPY OR IN COMBINATION WITH AN ANTIPSYCHOTIC AGENT" on Oct 31, 2024. With publication no. WO/2025/101418, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ETKIN, Amit (c/o Alto Neuroscience, Inc.650 Castro Street, Suite 450Mountain View, California 94041)...